Robinhood’s Top Crypto Executive Departs Company

CryptoProwl

Mon, May 25, 2026 astatine 8:10 AM CDT 1 min read

The apical cryptocurrency enforcement astatine Robinhood Markets (NASDAQ: $HOOD) is leaving the company. 

Tanya Denisova, main operating serviceman of Robinhood Crypto, is departing aft 5 years astatine the online brokerage. 

The departure comes aft Robinhood missed its first-quarter net and gross targets connected Wall Street, a disappointing effect the institution blamed mostly connected depressed crypto prices. 

More From Cryptoprowl:

• Ripple, The Company Behind XRP, Is Valued At $50 Billion

• Eightco Secures $125 Million Investment From Bitmine And ARK Invest, Shares Surge

• Blockchain Projects Decline 75% As Developers Shift To A.I.

• Stanley Druckenmiller Says Stablecoins Could Reshape Global Finance

• New York Stock Exchange Invests $600 Million In Polymarket

During their net call, Robinhood’s enactment squad said little prices for Bitcoin (CRYPTO: $BTC) and Ethereum (CRYPTO: $ETH) led to weaker crypto trading activities connected their platform. 

Crypto-related revenue, 1 of Robinhood’s biggest sources of income, fell 47% year-over-year to $134 cardinal U.S. successful Q1 of this year. That was down from $252 cardinal U.S. a twelvemonth earlier. 

Denisova’s departure besides comes aft absorption said they purpose to trim the company’s reliance connected volatile cryptocurrencies and reposition the business.

Robinhood enables users to commercialized stocks, exchange-traded funds (ETFs), options, and cryptocurrencies done a mobile-first app. 

In caller years, the institution has expanded its offerings to besides see status accounts, currency absorption services, and recognition cards. 

Robinhood presently offers commission-free trading for large integer assets specified arsenic Bitcoin 
And Ethereum straight wrong its app.

The institution besides provides crypto wallets, onchain transfers, and staking services successful prime markets. No announcement astir who, if anyone, volition regenerate Denisova has been made. 

HOOD banal has declined 36% this twelvemonth to commercialized astatine $73.64 U.S. per share.